NRAS G12S

Clinical trials for NRAS G12S explained in plain language.

Never miss a new study

Get alerted when new NRAS G12S trials appear

Sign up with your email to follow new studies for NRAS G12S, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New immunotherapy targets tough cancers with gene mutations

Disease control Ongoing

This study tests an experimental immunotherapy called ELI-002 7P in people with pancreatic or other solid tumors that have specific KRAS or NRAS gene mutations. The treatment aims to help the immune system recognize and attack cancer cells after standard therapies like surgery an…

Matched conditions: NRAS G12S

Phase: PHASE1, PHASE2 • Sponsor: Elicio Therapeutics • Aim: Disease control

Last updated May 11, 2026 20:47 UTC

NRAS G12S

Get alerted when new NRAS G12S trials appear

New immunotherapy targets tough cancers with gene mutations